HEADER IMMUNE SYSTEM 20-SEP-09 3A7B TITLE CRYSTAL STRUCTURE OF TLR2-STREPTOCOCCUS PNEUMONIAE LIPOTEICHOIC ACID TITLE 2 COMPLEX CAVEAT 3A7B NAG A 821 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TOLL-LIKE RECEPTOR 2, VARIABLE LYMPHOCYTE RECEPTOR B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN, UNP RESIDUES 1-506(MOUSE), UNP COMPND 5 RESIDUES 133-200(INSHORE HAGFISH); COMPND 6 SYNONYM: TLR2, VLRB.61; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS, EPTATRETUS BURGERI; SOURCE 3 ORGANISM_COMMON: MOUSE, INSHORE HAGFISH; SOURCE 4 ORGANISM_TAXID: 10090, 7764; SOURCE 5 GENE: TLR2; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HI-5; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PVL1393 KEYWDS TOLL-LIKE RECEPTOR, LIPOTEICHOIC ACID, LEUCINE RICH REPEAT, CELL KEYWDS 2 MEMBRANE, CYTOPLASMIC VESICLE, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE KEYWDS 3 RESPONSE, INFLAMMATORY RESPONSE, MEMBRANE, RECEPTOR, TRANSMEMBRANE, KEYWDS 4 PHOSPHOPROTEIN, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.Y.KANG,M.S.JIN,J.-O.LEE REVDAT 6 01-NOV-23 3A7B 1 HETSYN REVDAT 5 29-JUL-20 3A7B 1 CAVEAT COMPND REMARK SEQADV REVDAT 5 2 1 HET HETNAM FORMUL LINK REVDAT 5 3 1 SITE ATOM REVDAT 4 09-AUG-17 3A7B 1 SOURCE REVDAT 3 13-JUL-11 3A7B 1 VERSN REVDAT 2 09-FEB-10 3A7B 1 JRNL REVDAT 1 24-NOV-09 3A7B 0 JRNL AUTH J.Y.KANG,X.NAN,M.S.JIN,S.-J.YOUN,Y.H.RYU,S.MAH,S.H.HAN, JRNL AUTH 2 H.LEE,S.-G.PAIK,J.-O.LEE JRNL TITL RECOGNITION OF LIPOPEPTIDE PATTERNS BY TOLL-LIKE RECEPTOR JRNL TITL 2 2-TOLL-LIKE RECEPTOR 6 HETERODIMER JRNL REF IMMUNITY V. 31 873 2009 JRNL REFN ISSN 1074-7613 JRNL PMID 19931471 JRNL DOI 10.1016/J.IMMUNI.2009.09.018 REMARK 2 REMARK 2 RESOLUTION. 2.53 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.53 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 151024.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 39965 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4014 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3995 REMARK 3 BIN R VALUE (WORKING SET) : 0.3140 REMARK 3 BIN FREE R VALUE : 0.3720 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 453 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4355 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 269 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.66000 REMARK 3 B22 (A**2) : 6.14000 REMARK 3 B33 (A**2) : -4.47000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.37 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.48 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 50.33 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : LIGAND.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 5 : LIGAND.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3A7B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1000028901. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SILICON 111 REMARK 200 OPTICS : SILICON 111 REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40005 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 5.840 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07700 REMARK 200 FOR THE DATA SET : 42.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.26200 REMARK 200 FOR SHELL : 5.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2Z81 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 73.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50MM AMMONIUM CITRATE PH 7.0, 20% PEG REMARK 280 4000, 30% ETHYLENE GLYCOL, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.28900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 107.32900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.59500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 107.32900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.28900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.59500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LEU A 2 REMARK 465 ARG A 3 REMARK 465 ALA A 4 REMARK 465 LEU A 5 REMARK 465 TRP A 6 REMARK 465 LEU A 7 REMARK 465 PHE A 8 REMARK 465 TRP A 9 REMARK 465 ILE A 10 REMARK 465 LEU A 11 REMARK 465 VAL A 12 REMARK 465 ALA A 13 REMARK 465 ILE A 14 REMARK 465 THR A 15 REMARK 465 VAL A 16 REMARK 465 LEU A 17 REMARK 465 PHE A 18 REMARK 465 SER A 19 REMARK 465 LYS A 20 REMARK 465 ARG A 21 REMARK 465 CYS A 22 REMARK 465 SER A 23 REMARK 465 ALA A 24 REMARK 465 GLN A 25 REMARK 465 THR A 576 REMARK 465 LEU A 577 REMARK 465 VAL A 578 REMARK 465 PRO A 579 REMARK 465 ARG A 580 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 40 23.97 35.68 REMARK 500 ARG A 41 -149.99 -78.90 REMARK 500 ASN A 62 -152.55 -110.46 REMARK 500 SER A 86 -140.03 -92.14 REMARK 500 ARG A 87 42.22 -141.56 REMARK 500 ASN A 110 -162.40 -121.50 REMARK 500 PRO A 135 26.78 -72.90 REMARK 500 ASN A 158 -176.70 -171.08 REMARK 500 GLN A 192 -5.14 94.51 REMARK 500 GLU A 246 95.81 -67.05 REMARK 500 ARG A 257 -72.37 -86.97 REMARK 500 ASP A 285 -121.02 -94.05 REMARK 500 ASP A 286 57.43 -67.91 REMARK 500 ASP A 294 110.84 63.65 REMARK 500 PHE A 295 157.51 -45.25 REMARK 500 ASN A 296 -51.11 -137.00 REMARK 500 PRO A 297 97.55 -52.84 REMARK 500 SER A 304 43.30 30.17 REMARK 500 PRO A 320 -79.72 -56.82 REMARK 500 TYR A 326 -107.14 -83.31 REMARK 500 ASP A 327 -59.36 -177.59 REMARK 500 LEU A 328 -2.18 69.84 REMARK 500 ASN A 345 61.74 33.21 REMARK 500 ASN A 370 -152.98 -122.05 REMARK 500 ALA A 381 53.80 -108.73 REMARK 500 TRP A 386 54.45 38.60 REMARK 500 ASN A 397 -153.21 -129.01 REMARK 500 THR A 453 27.06 -67.52 REMARK 500 ASN A 467 -159.80 -135.62 REMARK 500 ASN A 468 51.25 -118.48 REMARK 500 ILE A 506 33.40 -146.59 REMARK 500 GLN A 510 41.45 74.90 REMARK 500 LEU A 522 69.19 -101.99 REMARK 500 THR A 523 1.24 -57.79 REMARK 500 SER A 538 -154.45 -170.85 REMARK 500 ILE A 542 23.31 39.84 REMARK 500 SER A 565 118.38 -169.24 REMARK 500 ARG A 570 68.91 -152.10 REMARK 500 CYS A 574 103.68 41.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 LIPOTEICHOIC ACID LABELED AS LTC WAS PURIFIED FROM STREPTOCOCCUS REMARK 600 PNEUMONIA REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3A79 RELATED DB: PDB REMARK 900 TLR2-TLR6-PAM2CSK4 COMPLEX REMARK 900 RELATED ID: 3A7C RELATED DB: PDB REMARK 900 TLR2-PE-DTPA COMPLEX DBREF 3A7B A 1 506 UNP Q9QUN7 TLR2_MOUSE 1 506 DBREF 3A7B A 509 576 UNP Q4G1L2 Q4G1L2_EPTBU 133 200 SEQADV 3A7B ALA A 507 UNP Q4G1L2 LINKER SEQADV 3A7B SER A 508 UNP Q4G1L2 LINKER SEQADV 3A7B LEU A 577 UNP Q4G1L2 EXPRESSION TAG SEQADV 3A7B VAL A 578 UNP Q4G1L2 EXPRESSION TAG SEQADV 3A7B PRO A 579 UNP Q4G1L2 EXPRESSION TAG SEQADV 3A7B ARG A 580 UNP Q4G1L2 EXPRESSION TAG SEQRES 1 A 580 MET LEU ARG ALA LEU TRP LEU PHE TRP ILE LEU VAL ALA SEQRES 2 A 580 ILE THR VAL LEU PHE SER LYS ARG CYS SER ALA GLN GLU SEQRES 3 A 580 SER LEU SER CYS ASP ALA SER GLY VAL CYS ASP GLY ARG SEQRES 4 A 580 SER ARG SER PHE THR SER ILE PRO SER GLY LEU THR ALA SEQRES 5 A 580 ALA MET LYS SER LEU ASP LEU SER PHE ASN LYS ILE THR SEQRES 6 A 580 TYR ILE GLY HIS GLY ASP LEU ARG ALA CYS ALA ASN LEU SEQRES 7 A 580 GLN VAL LEU ILE LEU LYS SER SER ARG ILE ASN THR ILE SEQRES 8 A 580 GLU GLY ASP ALA PHE TYR SER LEU GLY SER LEU GLU HIS SEQRES 9 A 580 LEU ASP LEU SER ASP ASN HIS LEU SER SER LEU SER SER SEQRES 10 A 580 SER TRP PHE GLY PRO LEU SER SER LEU LYS TYR LEU ASN SEQRES 11 A 580 LEU MET GLY ASN PRO TYR GLN THR LEU GLY VAL THR SER SEQRES 12 A 580 LEU PHE PRO ASN LEU THR ASN LEU GLN THR LEU ARG ILE SEQRES 13 A 580 GLY ASN VAL GLU THR PHE SER GLU ILE ARG ARG ILE ASP SEQRES 14 A 580 PHE ALA GLY LEU THR SER LEU ASN GLU LEU GLU ILE LYS SEQRES 15 A 580 ALA LEU SER LEU ARG ASN TYR GLN SER GLN SER LEU LYS SEQRES 16 A 580 SER ILE ARG ASP ILE HIS HIS LEU THR LEU HIS LEU SER SEQRES 17 A 580 GLU SER ALA PHE LEU LEU GLU ILE PHE ALA ASP ILE LEU SEQRES 18 A 580 SER SER VAL ARG TYR LEU GLU LEU ARG ASP THR ASN LEU SEQRES 19 A 580 ALA ARG PHE GLN PHE SER PRO LEU PRO VAL ASP GLU VAL SEQRES 20 A 580 SER SER PRO MET LYS LYS LEU ALA PHE ARG GLY SER VAL SEQRES 21 A 580 LEU THR ASP GLU SER PHE ASN GLU LEU LEU LYS LEU LEU SEQRES 22 A 580 ARG TYR ILE LEU GLU LEU SER GLU VAL GLU PHE ASP ASP SEQRES 23 A 580 CYS THR LEU ASN GLY LEU GLY ASP PHE ASN PRO SER GLU SEQRES 24 A 580 SER ASP VAL VAL SER GLU LEU GLY LYS VAL GLU THR VAL SEQRES 25 A 580 THR ILE ARG ARG LEU HIS ILE PRO GLN PHE TYR LEU PHE SEQRES 26 A 580 TYR ASP LEU SER THR VAL TYR SER LEU LEU GLU LYS VAL SEQRES 27 A 580 LYS ARG ILE THR VAL GLU ASN SER LYS VAL PHE LEU VAL SEQRES 28 A 580 PRO CYS SER PHE SER GLN HIS LEU LYS SER LEU GLU PHE SEQRES 29 A 580 LEU ASP LEU SER GLU ASN LEU MET VAL GLU GLU TYR LEU SEQRES 30 A 580 LYS ASN SER ALA CYS LYS GLY ALA TRP PRO SER LEU GLN SEQRES 31 A 580 THR LEU VAL LEU SER GLN ASN HIS LEU ARG SER MET GLN SEQRES 32 A 580 LYS THR GLY GLU ILE LEU LEU THR LEU LYS ASN LEU THR SEQRES 33 A 580 SER LEU ASP ILE SER ARG ASN THR PHE HIS PRO MET PRO SEQRES 34 A 580 ASP SER CYS GLN TRP PRO GLU LYS MET ARG PHE LEU ASN SEQRES 35 A 580 LEU SER SER THR GLY ILE ARG VAL VAL LYS THR CYS ILE SEQRES 36 A 580 PRO GLN THR LEU GLU VAL LEU ASP VAL SER ASN ASN ASN SEQRES 37 A 580 LEU ASP SER PHE SER LEU PHE LEU PRO ARG LEU GLN GLU SEQRES 38 A 580 LEU TYR ILE SER ARG ASN LYS LEU LYS THR LEU PRO ASP SEQRES 39 A 580 ALA SER LEU PHE PRO VAL LEU LEU VAL MET LYS ILE ALA SEQRES 40 A 580 SER ASN GLN LEU LYS SER VAL PRO ASP GLY ILE PHE ASP SEQRES 41 A 580 ARG LEU THR SER LEU GLN LYS ILE TRP LEU HIS THR ASN SEQRES 42 A 580 PRO TRP ASP CYS SER CYS PRO ARG ILE ASP TYR LEU SER SEQRES 43 A 580 ARG TRP LEU ASN LYS ASN SER GLN LYS GLU GLN GLY SER SEQRES 44 A 580 ALA LYS CYS SER GLY SER GLY LYS PRO VAL ARG SER ILE SEQRES 45 A 580 ILE CYS PRO THR LEU VAL PRO ARG MODRES 3A7B ASN A 414 ASN GLYCOSYLATION SITE MODRES 3A7B ASN A 442 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET NAG A 821 14 HET LTC A 581 54 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM LTC (2S)-1-({3-O-[2-(ACETYLAMINO)-4-AMINO-2,4,6-TRIDEOXY- HETNAM 2 LTC BETA-D-GALACTOPYRANOSYL]-ALPHA-D-GLUCOPYRANOSYL}OXY)- HETNAM 3 LTC 3-(HEPTANOYLOXY)PROPAN-2-YL (7Z)-PENTADEC-7-ENOATE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN LTC LIPOTEICHOIC ACID FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 4 LTC C39 H70 N2 O13 FORMUL 5 HOH *269(H2 O) HELIX 1 1 SER A 116 GLY A 121 1 6 HELIX 2 2 SER A 193 ILE A 197 5 5 HELIX 3 3 PHE A 212 LEU A 221 1 10 HELIX 4 4 THR A 262 LYS A 271 1 10 HELIX 5 5 LEU A 272 ILE A 276 5 5 HELIX 6 6 LEU A 328 GLU A 336 1 9 HELIX 7 7 PRO A 352 LEU A 359 1 8 HELIX 8 8 VAL A 373 ALA A 381 1 9 HELIX 9 9 SER A 401 LEU A 410 1 10 HELIX 10 10 ASP A 494 PHE A 498 5 5 HELIX 11 11 GLY A 517 LEU A 522 5 6 HELIX 12 12 ILE A 542 LYS A 551 1 10 SHEET 1 A23 SER A 29 CYS A 30 0 SHEET 2 A23 VAL A 35 ASP A 37 -1 O ASP A 37 N SER A 29 SHEET 3 A23 SER A 56 ASP A 58 1 O SER A 56 N CYS A 36 SHEET 4 A23 VAL A 80 ILE A 82 1 O ILE A 82 N LEU A 57 SHEET 5 A23 HIS A 104 ASP A 106 1 O ASP A 106 N LEU A 81 SHEET 6 A23 TYR A 128 ASN A 130 1 O ASN A 130 N LEU A 105 SHEET 7 A23 THR A 153 ASN A 158 1 O ARG A 155 N LEU A 129 SHEET 8 A23 SER A 175 ALA A 183 1 O GLU A 180 N LEU A 154 SHEET 9 A23 ASP A 199 HIS A 206 1 O THR A 204 N ILE A 181 SHEET 10 A23 VAL A 224 ARG A 230 1 O ARG A 230 N LEU A 205 SHEET 11 A23 LYS A 253 PHE A 256 1 O ALA A 255 N LEU A 229 SHEET 12 A23 GLU A 281 PHE A 284 1 O GLU A 283 N PHE A 256 SHEET 13 A23 THR A 311 ARG A 315 1 O THR A 313 N VAL A 282 SHEET 14 A23 ARG A 340 GLU A 344 1 O THR A 342 N ILE A 314 SHEET 15 A23 PHE A 364 ASP A 366 1 O ASP A 366 N VAL A 343 SHEET 16 A23 THR A 391 VAL A 393 1 O VAL A 393 N LEU A 365 SHEET 17 A23 SER A 417 ASP A 419 1 O ASP A 419 N LEU A 392 SHEET 18 A23 PHE A 440 ASN A 442 1 O PHE A 440 N LEU A 418 SHEET 19 A23 VAL A 461 ASP A 463 1 O ASP A 463 N LEU A 441 SHEET 20 A23 GLU A 481 TYR A 483 1 O TYR A 483 N LEU A 462 SHEET 21 A23 VAL A 503 LYS A 505 1 O VAL A 503 N LEU A 482 SHEET 22 A23 LYS A 527 TRP A 529 1 O TRP A 529 N MET A 504 SHEET 23 A23 GLU A 556 GLN A 557 1 O GLN A 557 N ILE A 528 SHEET 1 B 2 TYR A 66 ILE A 67 0 SHEET 2 B 2 THR A 90 ILE A 91 1 O THR A 90 N ILE A 67 SHEET 1 C 2 GLU A 164 ILE A 165 0 SHEET 2 C 2 ASN A 188 TYR A 189 1 O ASN A 188 N ILE A 165 SHEET 1 D 2 VAL A 260 LEU A 261 0 SHEET 2 D 2 THR A 288 LEU A 289 1 O THR A 288 N LEU A 261 SSBOND 1 CYS A 30 CYS A 36 1555 1555 2.03 SSBOND 2 CYS A 353 CYS A 382 1555 1555 2.05 SSBOND 3 CYS A 432 CYS A 454 1555 1555 2.04 SSBOND 4 CYS A 537 CYS A 562 1555 1555 2.04 SSBOND 5 CYS A 539 CYS A 574 1555 1555 2.04 LINK ND2 ASN A 414 C1 NAG A 821 1555 1555 1.43 LINK ND2 ASN A 442 C1 NAG B 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.39 CRYST1 68.578 83.190 214.658 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014582 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012021 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004659 0.00000